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We read with interest the article of Jahnukainen and
colleagues [1] who presented 26 patients with tubulointer-
stitial nephritis. Twelve patients (46%) presented bilateral
anterior uveitis associated with tubulointerstitial nephritis,
also known as tubulointerstitial nephritis and uveitis
(TINU) syndrome. One of these 12 patients developed
the uveitis prior to the nephrologic disease, in six, uveitis
was diagnosed within 2 weeks of the diagnosis of
nephritis, and in the remaining five between 3 and
15 months after onset of the nephrologic symptoms.
Despite the diagnosis of uveitis, seven patients presented
no ocular symptoms.
We followed a 14 year-old female adolescent with
unremarkable personal and familial history who com-
plained about fever and headache. The symptomatic
therapy did not improve the subjective complaints, and 5
weeks later, leukocyturia, tubular proteinuria, and glu-
cosuria ensued. Clinical examination was normal (body
weight 58.5 kg, height 168 cm, blood pressure 118/
70 mmHg, heart rate 76 beats/min); blood analysis
revealed a moderate anemia (hemoglobin 107 g/L)
together with thrombocytosis (platelets 573 G/L) and
elevated markers of inflammation (C-reactive protein
87 mg/L, erythrocyte sedimentation rate 76 mm/h).
Acute renal failure (creatinine up to 141 μmol/L ) and
persistent signs of tubular damage induced us to perform
a renal biopsy, which highlighted severe acute tubuloin-
terstitial nephritis. At that time, ophthalmological exam-
ination was normal, and the etiology of interstitial
nephritis was unknown. Therapy with systemic cortico-
steroids was started: methylprednisolone endovenous
10 mg/kg for 3 days, followed by oral prednisolone
80 mg daily, which was tapered in the following
4 months. Nephritis rapidly improved (creatinine and
urea decreased to normal values; glucosuria and tubular
proteinuria disappeared, Fig. 1). However, 2 months
later, still under high-dose systemic corticosteroids
(0.5 mg/kg/d), the patient presented with pain and redness
of both eyes. Ophthalmological examination revealed
anterior bilateral uveitis, which was successfully treated
with topical corticosteroids.
TINU syndrome was first described 1975 by Dobrin and
colleagues [2]. Uveitis usually follows nephritis, with a
delay of 3 months on average [3]. In our case, uveitis
ensued when the patient was still under systemic high-dose
corticosteroids (Fig. 1), as has been already described in the
literature [4]. The very interesting report of Jahnukainen et
al. [1] does not indicate whether uveitis developed during
therapy with high-dose systemic corticosteroids.
TINU syndrome is a rare diagnosis, which should be
suspected when a young patient presents with interstitial
nephritis. As uveitis may rarely also occur during high-dose
treatment with systemic corticosteroids and can be asymp-
tomatic, regular ophthalmological follow-up is warranted in
patients with tubulointerstitial nephritis.
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Fig. 1 A 14-year-old female adolescent developed bilateral anterior
uveitis during high-dose corticosteroid therapy 2 months after the
diagnosis of tubulointerstitial nephritis (arrow), allowing the final
diagnosis of tubulointerstitial nephritis and uveitis (TINU) syndrome.
Systemic corticosteroid dose is indicated in the text
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